Allium sativum L.

Sat, 19 Apr 2008 11:39:12 +0200


  • Abdullah, T. H., O. Kandil, A. Elkadi, and J. Carter. (1988) “Garlic revisited: Therapeutic for the major diseases of our time?” Journal of the National Medical Association 80(4):439-445.
  • Abdullah, T.H., Kirkpatrick, D. V. and Carter J. (1989) “Enhancement of Natural Killer cell activity in AIDS with garlic”. Deutsch Zeishrift fur Onkologie 21: 52-53.
  • Agarwal KC. (1996) “Therapeutic actions of garlic constituents”. Medical research reviews, , 16:111-124.
  • Ahmed, N. et al. (2001) Anticancer Research 5: .
  • Al-Naghdy, S. A., Abdel-Rahman, M.O. and Heiba H. I.. (1988) “Evidence for some prostaglandins in Allium sativum extracts”. Phytotherapy Research 2(4):196-197.
  • Aqel MB, Gharaibah MN, Salhab AS. (1991) “Direct relaxant effects of garlic juice on smooth and cardiac muscles”. Journal of ethnopharmacology, 33:13-19.
  • Augusti, K. T., Matthew, P. T. (1975) Experientia 31: 148-149..
  • Beck H, Wagnerk G. (1994) “Inhibition of cholesterol biosynthesis by allicin and ajoene in rat hepatocytes and Hep62 cells”. Biochimica biophysica acta, 1213:57-62.
  • Bethold HK, Sudhop T, von Bergmann K. (1998) “Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: a randomized controlled trial”. JAMA; 279: 1900.
  • Bianchi A,Adamoli R, Durante A, Saibene A (1997) Piante medicinali e AIDS: Piante antivirali e immunomodulanti utilizzate nell'infezione da HIV e nelle malattie correlate Milano,Tecniche Nuove pp. 261-272
  • Block E. (1985) “The chemistry of garlic and onions”. Scientific American, 252:94-99.
  • Block, E. (1986) “Antithrombic agent of garlic: A lesson from 5,000 years of folk medicine”. In: R. P. Steiner, ed. Folk Medicine: The Art and the Science. American Chemical Society, Washington, D.C., pp. 125 - 138.
  • Block, E., Ahmad, S. Jain M.K., Crecely, R.W. Apitz-Castro, R. and Rosa M.R. (1984). J. Am. Chem. Soc. 106:.
  • Boik J (2001) Natural compounds in cancer therapy. Oregon Medical Press
  • Bordia A et al. (1977) “Effect of essential oil of garlic on serum fibrinolytic activity in patients with coronary artery disease”. Atherosclerosis, 26:379-386.
  • Bordia A. (1986) “Klinische Untersuchung zur Wirksamkeit von Knoblauch”. Apotheken-Magazin, 6:128-131.
  • Breithaupt-Grogler K, Ling M, Boudoulais H et al (1997) “Protective effect of chronic garlic intake on elastic properties of aorta in the elderly” Circulation, 96:
  • Brosche T, Platt D. (1990) “Garlic as a phytogenic lipid lowering drug: a review of clinical trials with standardized garlic powder preparation”. Fortschritte der Medizin, 108:703-706.
  • Brosche T, Platt D. (1991)”Garlic”. British medical journal, 303, 785
  • Burfield T (2000) Natural Aromatic materials - Odours and Origins. The Atlantic Institute of Aromatherapy
  • Chutani SK, Bordia A. (1981) “The effect of fried versus raw garlic on fibrinolytic activity in man”. Atherosclerosis, 38:417-421.
  • Damrau F, Ferguson EA. (1949) “The modus operandi of carminatives”. Review of gastroenterology 16:411-419.
  • Das I, Khan NS, Sooranna SR. (1995) “Nitric oxide synthetase activation is a unique mechanism of garlic action”. Biochemical Society transactions, 23:S136.
  • DeCandolle, A. (1908). The Origin of Cultivated Plants. New York
  • Elwood PC, Beswick AD, O'Brien JR, Yarnell JW, Layzell JC, Limb ES. (1993) “Inter-relationships between haemostatic tests and the effects of some dietary determinants in the Caerphilly cohort of older men.” Blood Coagul Fibrinolysis;4(4):529-36
  • Ernst, E. (1987) “Cardiovascular effects of garlic (Allium sativum): A review”. Pharmatherapeutica. 5(2): 83-89.
  • Fleischauer AT, Poole C, Arab L (2000) “Garlic consumption and cancer prevention: meta-analyses of colorectal and stomach cancer”Am J Clin Nutr, 72:
  • Gadkari JV, Joshi VD. (1991) “Effect of ingestion of raw garlic on serum cholesterol level, clotting time and fibrinolytic activity in normal subjects.” J Postgrad Med;37(3):128-31
  • Gadkari, J. V., Joshi, V. D. (1991) J Postgrad Med 37: 128-131.
  • Gaffen JD, Tavares IA, Bennett A. (1984) “The effect of garlic extracts on contractions of rat gastric fundus and human platelet aggregation.” Journal of pharmacy and pharmacology, 36:272-274.
  • Gebhardt R, Beck H, Wagner KG. (1994) “Inhibition of cholesterol biosynthesis by allicin and ajoene in rat hepatocytes and HepG2 cells.” Biochimica biophysica acta, 1213:57-62.
  • Gebhardt R. (1993) “Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes.” Lipids ;28(7):613-9
  • Gebhardt R. (1995) “Amplification of palmitate-induced inhibition of cholesterol biosynthesis in cultured rat hepatocytes by garlic-derived organosulfur compounds.” Phytomedicine, , 2:29-34.
  • Gruenwald J, Brendler T, Jaenicke C et al, eds. (1998) PDR for Herbal Medicines. Montvale, NJ: Medical Economics Company.
  • Grünwald J. (1992) “Knoblauch: Cholesterinsenkende Wirkung doppelblind nachgewiesen.” Deutsche Apotheker Zeitung, 132:1356.
  • Harenberg J, Giese C, Zimmermann R. (1988) “Effects of dried garlic on blood coagulation, fibrinolysis, platelet aggregation, and serum cholesterol levels in patients with hyperlipoproteinemia.” Atherosclerosis, 74:247-249.
  • Harper, D. (1997) Early Chinese Medical Literature: The Mawguandi medical manuscripts. Kegan paul International.
  • Isaacsohn JL, Moser M, Stein EA et al. (1998) “Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial.” Arch Intern Med; 158: .
  • Jamaluddin MP, Krishnan LK, Thomas A. (1988) “Ajoene inhibition of platelet aggregation: possible mediation by a hemoprotein.” Biochemical and biophysical research communications, 153:479-486.
  • Jones, W. H. S. (1964) Pliny Natural History in Ten Volumes. Vol. VI. The Loeb Classical Library. Cambridge, Mass.: Harvard University Press.
  • Joshi, D.J., Dikshit R. K., and Mansuri S.M.. (1987) “Gastrointestinal actions of garlic oil. Phytotherapy Research 1(3):140-141.
  • Jung H, Kiesewetter H. (1991) “Einfluss einer Fettbelastung auf Plasmalipide und kapillare Hautdurchblutung unter Knoblauch.” Medizinische Welt, 42:14-17.
  • Kato, Yoshio. (1973) Garlic, The Unknown Miracle Worker. Amagasakici, Japan: Oyama Garlic Laboratory.
  • Kendler, B.S. (1987) “Garlic (Allium sativum) and onion (Allium cepa): A review of their relationship to cardiovascular disease.” Preventive Medicine 16:670-85.
  • Kiesewetter H et al. (1993) “Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischaemic attack.” European journal of clinical pharmacology, 45:333-336.
  • Kiesewetter H, Jung F, Jung EM, Blume J, Mrowietz C, Birk A, Koscielny J, Wenzel E, (1993) “Effects of garlic coated tablets in peripheral arterial occlusive disease.” Clin Investig;71(5):383-6
  • Kiesewetter H, Jung F, Pindur G, Jung EM, Mrowietz C, Wenzel E (1991) “Effect of garlic on thrombocyte aggregation, microcirculation, and other risk factors.” Int J Clin Pharmacol Ther Toxicol;29(4):151-5
  • Kiesewetter H, Jung F. (1991) “Beeinflusst Knoblauch die Atherosklerose?” Medizinische Welt, 42:21-23.
  • Kleijnen, J., Knipschild P. and Terriet G. (1989) “Garlic, onions and cardiovascular risk factors. A review of the evidence from human experiments with emphasis on commercially available preparations. Brit. J. Clin. Pharmac. 28: 535-544.
  • Koch HP, Lawson LD, eds. (1996) Garlic, the science and therapeutic application of Allium sativum l. and related species. Baltimore, Williams and Wilkins.
  • Lawson LD (1998) “Effect of garlic on serum lipids”. J Am Med Assoc, 280:1568
  • Lawson LD et al. (1991) “HPLC analysis of allicin and other thiosulfinates in garlic clove homogenates.” Planta medica, 57:263-270
  • Lawson LD (1996) "The composition and chemistry of garlic cloves and processed garlic" in HP Koch and LD Lawson Garlic - The science and therapeutic applications of Allium sativum L. and related species 2nd edition. Williams and Wilkins, Baltimora, USA
  • Lee, K. T. et al. (2001) Archives of Pharmaceutical Research 24: 44-50.
  • Leung AY e Foster S (1999) Enciclopedia delle piante medicinali. Roma, Aporie, pp. 16-19
  • Mabberly, D.J. (1987) The Plant Book. New York: Cambridge University Press.
  • Mader FH. (1990) “Treatment of hyperlipidemia with garlic-powder tablets. Evidence from the German Association of General Practitioner's multicentric placebo-controlled, double-blind study.” Arzneimittel-Forschung, 40:.
  • Manniche, Lise. (1989) An Ancient Egyptian Herbal. Austin, Tex. University of Texas Press.
  • Mathew PT, Augusti KT. (1973) “Studies on the effects of allicin (diallyl disulfide-oxide) on alloxan diabetes. Part I. Hypoglycemic action and enhancement of serum insulin effect and glycogen synthesis.” Indian journal of biochemistry and biophysics, 10:209-221.
  • McCrindle BW, Helden E, Conner WT. (1999) “Garlic extract therapy in children with hypercholesterolemia.” Arch Pediatr Adolesc Med; 152: .
  • McMahon FG, Vargas R. (1993) “Can garlic lower blood pressure? A pilot study.” Pharmacotherapy 13(4):406-7
  • Monti L, Longo R (2001) “L'Aglio, una vecchia nuova pianta medicinale” Acta Phytoterapeutica, Vol IV, n. 1:15-28
  • Moriguchi, T e Saito, H (2000) “Aged Garlic Extract as a neurotrophic and anti-aging ageny” Piante Medicinali 3(1):114-128
  • Murray, MT (1995) The healing power of herbs. Prima Publ. pp. 121-131
  • Neil HA, Silagy CA, Lancaster T, Hodgeman J, Vos K, Moore JW, Jones L, Cahill J, Fowler GH. (1996) “Garlic powder in the treatment of moderate hyperlipidaemia: a controlled trial and meta-analysis.” J Royal Coll Phys London; 30(4): 329-334.
  • Nishimura, H. et al. (2000) Biofactors 13: 257-63.
  • Platt D, Brosche T, Jacob BG. (1992) “Cholesterin-senkende Wirkung von Knoblauch?” Deutsche Medizinische Wochenschrift, 117:962-963.
  • Rashid A, Hussain M, Khan HH. (1986) “Bioassay for prostaglandin-like activity of garlic extract using isolated rat fundus strip and rat colon preparation.” Journal of the Pakistan Medical Association, 36:138-141.
  • Reuter, H. D. (1995) “Allium sativum and Allium ursinum: Part 2. Pharmacology and Medicinal Application.” Phytomedicine 2(1):73-91.
  • Reuter, H. D.; Koch, H. P.; Lawson, L. D. (1996) In Koch, H. P.; Lawson, L. D. Eds: Garlic: the Science and Therapeutic Application of Allium sativum L. and Related Species;. Williams & Wilkins: Baltimore; pp 135-212.
  • Rose, K. D., et al. (1990) Neurosurgery 26: 880-882.
  • Rosen, R. T. et al. (2000) Biofactors 13: 241-9.
  • Rotzsch W, Richter V, Rassoul F, Walper A. (1992) “Postprandial lipemia under treatment with Allium sativum. Controlled double-blind study of subjects with reduced HDL2-cholesterol.” Arzneimittelforschung 42(10):1223-7
  • Sendl A. (1995) “Allium sativum and Allium ursinum, Part 1. Chemistry, analysis, history, botany.” Phytomedicine, , 4:323-339.
  • Sendl, A. et al. (1992) Planta Medica 58: 8-13.
  • Siegel G et al. (1991) “Potassium channel activation, hyperpolarization, and vascular relaxation.” Zeitschrift für Kardiologie, 80:9-24.
  • Siegel G et al. (1992) “Potassium channel activation in vascular smooth muscle.” In: Frank GB, ed. Excitation-contraction coupling in skeletal, cardiac, and smooth muscle. New York, Plenum Press:53-72.
  • Silagy C, Neil A. (1994) “Garlic as a lipid lowering agent-a meta-analysis.” J R Coll Physicians Lond ;28(1):39-45
  • Silagy CA, Neil HA. (1994) “A meta-analysis of the effect of garlic on blood pressure.” J Hypertens;12(4):463-8
  • Singh, K.V. and N. P. Shukla. (1984) “Activity of multiple resistant bacteria of garlic (Allium sativum) extract.” Fitoterapia 55(5):313-15.
  • Sitprija S et al. (1987) “Garlic and diabetes mellitus phase II clinical trial.” Journal of the Medical Association of Thailand, 70:223-227.
  • Soh CT. (1960) “The effects of natural food-preservative substances on the development and survival of intestinal helminth eggs and larvae. II. Action on Ancylostoma duodenale larvae.” American journal of tropical medicine and hygiene, 9:8-10.
  • Srivastava KC, Tyagi OD. (1993) “Effects of a garlic-derived principal (ajoene) on aggregation and arachidonic acid metabolism in human blood platelets.” Prostaglandins, leukotrienes, and essential fatty acids, 49:587-595.
  • Steiner, M, Khan, AH, Holbert D, et al (1996) “A double-blind, cross-over study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids” Am J Clin Nutr, 64:866-70
  • Stevens, P.F. (2001 onwards). Angiosperm Phylogeny Website. Version 5, May 2004 [and more or less continuously updated since].
  • Stevinson C, Pittler MH, Ernst E. (2000) “Garlic for treating hypercholesterolemia. A meta-analysis of randomised clinical trials.” Annals Internal Medicine; 133(6): 420-429
  • Sucur, M. (1980) Diabetol Croat 9: 323-338.
  • Sunter, W. H. (1991) Pharm J. 246: 722.
  • Superko HR, Krauss RM. (2000) “Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein (a).” J Am Coll Cardiol; 35: 321.
  • Tamaki, T.; Sonoki, S. (1999) Journal of Nutritional Science and Vitaminology 45: 213
  • Tang JL, Armitage JM, Lancaster T et al. (1998) “Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects.” BMJ; 316:
  • Teyssier, C. et al. (1999) Drug Metabolism and Disposition 27: 835-41.
  • Warchafsky,S., et al. (1993) “Effect of garlic on total serum cholesterol.” Annals of Internal Medicine, 119:599-605.
  • Warshafsky S, Kamer RS, Sivak SL. (1993) “Effect of garlic on total serum cholesterol. A meta-analysis.” Ann Intern Med; 119: 599-605).
  • Wolf S, Reim M. (1990) “Effect of garlic on conjunctival vessels: a randomised, placebocontrolled, double-blind trial.” British journal of clinical practice, 44:36-39.
  • Wren RC (revised by Williamson et Evans) (1988) Potter's New Cyclopedia of botanical drugs & preparations. Saffron Walden, CW Daniels pp. 124-125
  • Yeh YY, Yeh SM, (1994) “Garlic reduces plasma lipids by inhibiting hepatic cholesterol and triacylglycerol synthesis.” Lipids ;29(3):189-93
Sat, 19 Apr 2008 11:39:12 +0200


Licenza Creative Commons
Il database InfoErbe
è pubblicato con
Licenza Creative Commons

Marco Valussi
Luciano Posani

Copyright 2000 - 2005 Miro International Pty Ltd. All rights reserved. Mambo is Free Software released under the GNU/GPL License.